Skip to main content
Premium Trial:

Request an Annual Quote

Team Tracks Immune T Cell Consequences of Y Chromosome Loss, Bladder Cancer Consequences

A functional immune system capable of staving off cancer cells appears to rely on the presence of Y sex chromosomes in biological males, according to new research by a Cedars-Sinai Medical Center-led team reporting in Nature, while aging-related Y chromosome loss appears to bump up the risk of developing aggressive forms of bladder cancer. With the help of a Y chromosome-encoded gene expression-based score for loss of the chromosome, the researchers found that higher-than-usual rates of Y chromosome loss tended to coincide with more aggressive disease and poorer survival outcomes in 300 locally advanced, muscle invasive bladder cancer cases included in the Cancer Genome Atlas project, though follow-up analyses suggest that Y chromosome loss is also linked to improved response to checkpoint inhibitor immunotherapy. With a series of flow cytometry, single-nucleus RNA sequencing, spatial proteomic, and other experiments in cancer cell lines and mouse models of disease, they teased out ties between Y chromosome loss and the function of CD8-positive immune T cells in the tumor microenvironment. "Together, these results demonstrate that cancer cells with [loss of the Y chromosome] mutations alter T cell function, promoting T cell exhaustion, and sensitizing them to PD-1-targeted immunotherapy," the authors report. In a related Nature study, a University of Texas MD Anderson Cancer Center team considers sex-related differences in colorectal cancer, focusing on the consequences of increased expression of a histone demethylase gene found on the Y chromosome.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.